Status:

COMPLETED

Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.

Lead Sponsor:

Stanford University

Collaborating Sponsors:

SRI International

Johns Hopkins University

Conditions:

Smoking

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The major purpose of this exploratory developmental study will be to develop a patient-centered and feasible protocol for communicating genetic data as it relates to drug efficacy for smoking cessatio...

Detailed Description

Therefore, our specific aims are to: Aim 1: Conduct formative research to develop and refine a clinical protocol for a multi-component smoking cessation intervention, grounded in the extended paralle...

Eligibility Criteria

Inclusion

  • Inclusion and exclusion criteria are the same for participants in the formative interviews (Study A) and the feasibility RCT (Study B) except that Study A will include African American and European American smokers and Study B will include European American smokers.
  • Inclusion criteria:
  • Adults (aged 18 or older)
  • Currently smoke at least 10 cigarettes per day
  • Motivated to quit smoking (\>=5 on a 10-point Likert scale)
  • Have a telephone
  • Read and speak English.
  • Exclusion criteria:
  • Any medical contraindications for transdermal nicotine replacement therapy (NRT) or sustained-release bupropion hydrochloride (bupropion) use based on the package labels (e.g., for bupropion, risk of seizure)
  • DSM-IV Axis I diagnosis (other than nicotine dependence)
  • Subjects who meet criteria for current major depression, or who demonstrate evidence of suicidal ideation at screening will be referred to treatment for depression and will be excluded from the study
  • Must agree not to seek other treatment for smoking cessation during the study.

Exclusion

    Key Trial Info

    Start Date :

    July 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2011

    Estimated Enrollment :

    36 Patients enrolled

    Trial Details

    Trial ID

    NCT00991081

    Start Date

    July 1 2009

    End Date

    March 1 2011

    Last Update

    September 19 2012

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    SRI International

    Menlo Park, California, United States, 94025

    2

    Stanford University School of Medicine

    Stanford, California, United States, 94305

    3

    Group Health Research Institute

    Seattle, Washington, United States, 98101